Howe & Rusling’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-27
Closed -$3K 955
2020
Q3
$3K Buy
+27
New +$2.33K ﹤0.01% 642
2019
Q3
Sell
-20
Closed -$2K 839
2019
Q2
$2K Hold
20
﹤0.01% 660
2019
Q1
$2K Hold
20
﹤0.01% 666
2018
Q4
$1K Hold
20
﹤0.01% 732
2018
Q3
$2K Hold
20
﹤0.01% 710
2018
Q2
$1K Hold
20
﹤0.01% 740
2018
Q1
$1K Buy
+20
New +$976 ﹤0.01% 850
2016
Q3
Sell
-44
Closed -$1K 1057
2016
Q2
$1K Hold
44
﹤0.01% 895
2016
Q1
$0 Hold
44
﹤0.01% 1017
2015
Q4
$0 Sell
44
-800
-95% -$7.44K ﹤0.01% 1017
2015
Q3
$15K Sell
844
-210
-20% -$4.82K ﹤0.01% 428
2015
Q2
$31K Buy
1,054
+44
+4% +$1.1K 0.01% 348
2015
Q1
$22K Buy
1,010
+210
+26% +$5.33K ﹤0.01% 382
2014
Q4
$22K Hold
800
0.01% 380
2014
Q3
$16K Hold
800
﹤0.01% 416
2014
Q2
$14K Buy
+800
New +$11K ﹤0.01% 445

Other funds holding EXAS

Howe & Rusling's EXAS Position: Q4 2020 in Review

Howe & Rusling sold out of Exact Sciences (EXAS) in Q4 2020, closing a stake of 27 shares — an estimated $3K sold.

Howe & Rusling first reported a position in EXAS in Q2 2014 and held it in 16 quarters. The position peaked at $31K in Q2 2015. 622 funds tracked by Wall St. Rank hold EXAS as of Q4 2020.

  • Howe & Rusling reported no remaining Exact Sciences position as of Q4 2020 after selling out during the quarter.
  • Howe & Rusling sold 27 Exact Sciences shares in Q4 2020, an estimated $3K.
  • Howe & Rusling first reported a position in Exact Sciences in Q2 2014 and held it in 16 quarters.
  • Howe & Rusling's Exact Sciences position peaked at $31K in Q2 2015.
  • 622 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2020.

Based on Howe & Rusling's 13F filing for Q4 2020, filed 8 Feb 2021.